Centric Health Provides Market Update on Medical Cannabis Initiatives

About this update from Carerx Corporation

[{"type":"text","content":"\n\n\n\nCentric Health Provides Market Update on Medical Cannabis Initiatives\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, April 15, 2019\n\n\n\nTORONTO, April 15, 2019 /CNW/ - Centric Health Corporation (\"Centric Health\" or \"the Company\") (TSX: CHH), one of Canada's leading healthcare services companies, is pleased to provide a market update on its recent medical cannabis initiatives.\nDuring the first quarter of 2019, Centric Health continued the implementation of its medical cannabis strategy with Canopy Growth Corporation (\"Canopy Growth\"), its strategic partner. To date, Centric Health's clinical pharmacists have led several prescriber information evenings, as well as staff, resident and family education sessions, at long-term care and retirement homes. The Company's implementation plan remains on track and revenue generation has commenced through deliveries to the first 50 patients. Centric Health expects the adoption of medical cannabis to quickly accelerate as seniors, home care operators and medical practitioners continue to be educated on the benefits and uses of medical cannabis. \nAs part of its commitment to offering seniors full clinical oversight of their medical cannabis needs, Centric Health is excited to announce that it has collaborated with Apollo Cannabis Clinics (\"Apollo\"), one of Canada's leading medical cannabis research organizations, to assist with virtual assessments of potential medical cannabis candidates. Apollo's clinical team of physicians, healthcare practitioners and support staff will assist seniors in Centric Health serviced homes in determining if medical cannabis is suitable for them, as well as prescribing products and providing ongoing monitoring for eligible candidates.\nCentric Health will also be participating in the upcoming Ontario Long-Term Care Association (\"OLTCA\") medical cannabis pilot study, which is being led by Canopy Growth. The OLTCA study aims to measure how medical cannabis use can potentially displace other, less-desirable treatments and therapies in long-term care resident...

More updates from Carerx Corporation